serial intravitreal injections
Showing 1 - 25 of 5,909
Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)
Not yet recruiting
- Radiation Retinopathy
- Visual Impairment
- Faricimab
- fluocinolone acetonide
- (no location specified)
Apr 25, 2023
Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)
Recruiting
- Dry Age-related Macular Degeneration
- Intravitreal injection of CB-PRP
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023
Anxiety and Fear Trial in Manresa (Music)
Active, not recruiting
- Anxiety and Fear
- Music
-
Manresa, Barcelona, SpainEduard Pedemonte Sarrias
Jun 6, 2023
Retinal Disease Trial in San Antonio (IRX-101, Providone-Iodine)
Recruiting
- Retinal Disease
-
San Antonio, TexasR. Gary Lane, II MD
Mar 1, 2023
Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII
Completed
- Intravitreal Injection
- +4 more
- OSDI questionnaire
- SPEEDII questionnaire
-
Oklahoma City, OklahomaDean McGee Eye Institute
Nov 7, 2022
Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial
Recruiting
- Diabetic Macular Edema
- +4 more
- Anti-vascular endothelial growth factors (Anti-VEGFs)
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 8, 2022
Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)
Not yet recruiting
- Diabetic Macular Edema
- +8 more
-
Bakersfield, California
- +7 more
Aug 23, 2023
Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in Vienna (MacInfo presentation, Placebo
Recruiting
- Age-related Macular Degeneration
- +2 more
- MacInfo presentation
- Placebo presentation
-
Vienna, AustriaVienna Institute for Research in Ocular Surgery (VIROS), Hanusch
Jan 24, 2022
Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
- Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
- (no location specified)
Jun 6, 2023
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Pachychoroid Neovasculopathy Trial (Three monthly injections of intravitreal aflibercept)
Not yet recruiting
- Pachychoroid Neovasculopathy
- Three monthly injections of intravitreal aflibercept
- (no location specified)
Dec 14, 2022
Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,
Active, not recruiting
- Diabetic Macular Edema
- Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
- Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
-
Tehran, Iran, Islamic Republic ofOphthalmic Research Center
Oct 6, 2021
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)
Completed
- Proliferative Diabetic Retinopathy
- preoperative intravitreal injections of ranibizumab or conbercept
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 7, 2022
Retinal Telangiectasis, Coats Disease Trial in France (Anti-VEGF injections of bevacizumab, Laser)
Recruiting
- Retinal Telangiectasis
- Coats Disease
- Anti-VEGF injections of bevacizumab
- Laser
-
Cergy-Pontoise, France
- +4 more
Dec 17, 2021
Safety and Effectiveness of Brolucizumab in Diabetic Macular
Not yet recruiting
- Diabetic Macular Edema
- brolucizumab
- (no location specified)
Jul 17, 2023
Use of Aflibercept Injections Into Eye for Treatment of Eye
Recruiting
- Retinal Disease
- Aflibercept (BAY86-5321, Eylea)
-
Multiple Locations, MexicoMany locations
Aug 22, 2022
Pain, Acute Trial in Giza (bupivacaine 0.5% and oxubuprocaine)
Completed
- Pain, Acute
- bupivacaine 0.5% and oxubuprocaine
-
Giza, Haram, EgyptResearch Institute of Ophthamology
Sep 10, 2022
Endophthalmitis Trial in Toronto (Tap and Inject (TAI), Pars Plana Vitrectomy (PPV))
Recruiting
- Endophthalmitis
- Tap and Inject (TAI)
- Pars Plana Vitrectomy (PPV)
-
Toronto, Ontario, CanadaSt. Michael's Hospital Eye Clinic
Apr 26, 2021
Retinal Detachment With Multiple Breaks, Unspecified Eye, Proliferative Vitreoretinopathy Trial in Philadelphia (Intravitreal
Recruiting
- Retinal Detachment With Multiple Breaks, Unspecified Eye
- Proliferative Vitreoretinopathy
- Intravitreal aflibercept injection
- Sham control
-
Philadelphia, PennsylvaniaWills Eye Hospital
May 2, 2022
Central Retinal Vein Occlusion Trial in Paris, Strasbourg, Écully (Ophthalmologic exam at inclusion and 12 months after CRVO,
Recruiting
- Central Retinal Vein Occlusion
- Ophthalmologic exam at inclusion and 12 months after CRVO
- Treatment standardization with aflibercept
-
Paris, France
- +2 more
Oct 19, 2021
Macular Disease Trial in Omaha
Suspended
- Macular Disease
-
Omaha, Nebraska
- +1 more
Sep 16, 2022
Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))
Completed
- Radiation Retinopathy
- 0.5 mg ranibizumab
- Targeted Retinal Photocoagulation (TRP)
-
Dallas, Texas
- +3 more
Mar 24, 2021